Evidence map›Paper›PMID 39304906›Full record

ArticleVirology journal2024

High prevalence of HPV-56 and HPV-39 in Sari, Iran: an analysis of genotype distribution.

Arash Letafati, Ali Vasheghani Farahani, Mohammad Mostafa Baradaran Nasiri, Hossein Pourmoein, Omid Salahi Ardekani, Haniyeh Ahoodashty, Mohammad Bagher Hashemi-Soteh, Aniseh Dadgar, Parisa Behshood, Iman Rezaee Azhar and 1 more

Abstract read
In one paragraph

Article in Virology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Comprehensive National Strategy for HPV Prevention and Treatment in Iran.International journal of health policy and management · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Arash LetafatiResearch Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.
Ali Vasheghani FarahaniResearch Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.
Mohammad Mostafa Baradaran NasiriResearch Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.
Hossein PourmoeinResearch Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.
Omid Salahi ArdekaniResearch Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.
Haniyeh AhoodashtyResearch Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.
Mohammad Bagher Hashemi-SotehImmunogenetic Research Center, Molecular and Cell Biology Research Center, Faculty of Medicine, Mzandaran University of Medical Sciences, Sari, Iran.
Aniseh DadgarResearch Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.
Parisa BehshoodDepartment of Microbiology, Young Researchers and Elite Club, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
Iman Rezaee AzharResearch Center for Clinical Virology, Tehran University of Medical Science, Tehran, Iran.
Masoud ParsaniaDepartment of Microbiology, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. mparsania@iautmu.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman papillomavirus (HPV) is responsible for the most common sexually transmitted infection, particularly among sexually active individuals. Understanding the geographical distribution and epidemiology of the most prevalent HPV genotypes is essential for developing effective prevention strategies. Consequently, this study aimed to examine the distribution of HPV genotypes among HPV-positive women and men in Sari, the capital city of Mazandaran province in northern Iran. MATERIALS AND

methodsHPV DNA was extracted (PZP Company, Molecular IVD, Iran) from genital and cervical samples of the study participants. Genotyping was conducted for 90 cases utilizing the High + Low Papilloma Strip test (Operon Company, Spain). Demographic data were statistically analyzed in correlation with the virological data (STATA version 17).

resultsOverall, 67.7% (61 out of 90) of the cases tested positive for HPV, with 75% of those being classified as high-risk. The participant group consisted of 92% females (83) and 8% males (7). The highest HPV prevalence, 75% (36), was observed in females and males aged under 31, with the majority of positive cases belonging to high-risk genotypes. The most frequently identified genotypes were HPV-11 (23%), HPV-6 (21%), HPV-56 (18%), HPV-39 (16%), HPV-16, HPV-91, and HPV-66 each comprising (14%). HPV-56 was the most common high-risk genotype, accounting for 11 cases (18%), followed by HPV-39, which was present in 10 cases (16%).

conclusionThe prevalence of HPV infection was particularly high among individuals under the age of 31 for both genders, with men exhibiting a 100% infection rate. These findings emphasize the urgent need for targeted education aimed at the younger population and the implementation of infection control measures. Specifically, widespread HPV vaccination targeting HPV-6, HPV-11, HPV-39, and HPV-56 should be prioritized for the general population.

Indexed as

GenotypePapillomaviridaePapillomavirus InfectionsAdolescentAdultAgedAlphapapillomavirusCervix UteriDNA, ViralFemaleHuman Papillomavirus VirusesHumansIranMaleMiddle AgedPrevalenceDNA, ViralGenotypeHuman papilloma virusIranPrevalenceSariSexually-transmitted infections

Identifiers

PMID39304906
PMCPMC11414255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.